Literature DB >> 3209109

Macrophage heterogeneity in normal colonic mucosa and in inflammatory bowel disease.

M C Allison1, S Cornwall, L W Poulter, A P Dhillon, R E Pounder.   

Abstract

Immunohistological techniques using monoclonal antibodies were employed to study the morphology and phenotypic expression of macrophage like cells in ulcerative colitis, Crohn's colitis and histologically normal colonic mucosa. The antibody RFD1 identifies interdigitating (antigen presenting) cells whereas RFD7 binds to mature tissue macrophages. In normal colonic mucosa, the majority of cells recognised by these reagents were positive for Class II antigen expression and a median 87% (range 80-95%) were positive for both RFD1 and RFD7, with 6.5% (ranges 1-14%) positive for either antibody alone. There was much greater macrophage heterogeneity in the ulcerative colitis and Crohn's colitis biopsies than in normal mucosa. Clusters of RFD9+ cells (epithelioid cells) were found in Crohn's colitis and, to a lesser extent, in ulcerative colitis. Some Crohn's colitis sections showed replacement of the normal colonic macrophage phenotype with RFD1-RFD7+ cells (classical scavenger macrophages). The degree of this replacement correlated with the histological severity of the disease. By contrast, large numbers of RFD1+ RFD7- cells, with long dendritic processes, were found in intimate association with the lymphoid infiltrates in the lamina propria of the ulcerative colitis sections. Future studies of the factors controlling macrophage differentiation in tissues may help to explain the greater macrophage heterogeneity in inflammatory bowel disease and the differences between ulcerative colitis and Crohn's colitis observed in this study.

Entities:  

Mesh:

Year:  1988        PMID: 3209109      PMCID: PMC1433822          DOI: 10.1136/gut.29.11.1531

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  14 in total

1.  Intestinal fine structure in Crohn's disease. Lysosomal inclusions in epithelial cells and macrophages.

Authors:  J Thyberg; W Graf; P Klingenström
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1981

2.  The involvement of dendritic cells in chronic inflammatory disease.

Authors:  L W Poulter; G Janossy
Journal:  Scand J Immunol       Date:  1985-05       Impact factor: 3.487

3.  Macrophage turnover in Crohn's disease and ulcerative colitis.

Authors:  G Meuret; A Bitzi; B Hammer
Journal:  Gastroenterology       Date:  1978-03       Impact factor: 22.682

4.  Acid hydrolases in monocytes from patients with inflammatory bowel disease, chronic liver disease, and rheumatoid arthritis.

Authors:  N K Ganguly; J G Kingham; B Lloyd; R S Lloyd; C P Price; D R Triger; R Wright
Journal:  Lancet       Date:  1978-05-20       Impact factor: 79.321

5.  Role of veiled cells in lymphocyte activation.

Authors:  S C Knight; B M Balfour; J O'Brien; L Buttifant; T Sumerska; J Clarke
Journal:  Eur J Immunol       Date:  1982-12       Impact factor: 5.532

Review 6.  The origin, morphology, and function of epithelioid cells.

Authors:  J L Turk; R B Narayanan
Journal:  Immunobiology       Date:  1982-04       Impact factor: 3.144

7.  Monoclonal antibodies specific for human monocytes, granulocytes and endothelium.

Authors:  N Hogg; S MacDonald; M Slusarenko; P C Beverley
Journal:  Immunology       Date:  1984-12       Impact factor: 7.397

8.  Monoclonal antibodies distinguish macrophages and epithelioid cells in sarcoidosis and leprosy.

Authors:  C S Munro; D A Campbell; L A Collings; L W Poulter
Journal:  Clin Exp Immunol       Date:  1987-05       Impact factor: 4.330

9.  Heterogeneity of HLA-DR-positive histiocytes in human intestinal lamina propria: a combined histochemical and immunohistological analysis.

Authors:  W S Selby; L W Poulter; S Hobbs; D P Jewell; G Janossy
Journal:  J Clin Pathol       Date:  1983-04       Impact factor: 3.411

10.  The involvement of dendritic cells in the cutaneous lesions associated with tuberculoid and lepromatous leprosy.

Authors:  L A Collings; M F Waters; L W Poulter
Journal:  Clin Exp Immunol       Date:  1985-12       Impact factor: 4.330

View more
  35 in total

Review 1.  Potential prospects of nanomedicine for targeted therapeutics in inflammatory bowel diseases.

Authors:  Madharasi V A Pichai; Lynnette R Ferguson
Journal:  World J Gastroenterol       Date:  2012-06-21       Impact factor: 5.742

2.  Differential expression of CD25 (interleukin-2 receptor) on lamina propria T cells and macrophages in the intestinal lesions in Crohn's disease and ulcerative colitis.

Authors:  M Y Choy; J A Walker-Smith; C B Williams; T T MacDonald
Journal:  Gut       Date:  1990-12       Impact factor: 23.059

3.  Interleukin-2 receptor expression.

Authors:  Y R Mahida
Journal:  Gut       Date:  1991-04       Impact factor: 23.059

Review 4.  Whipple's disease: a macrophage disease.

Authors:  Benoît Desnues; Melanie Ihrig; Didier Raoult; Jean-Louis Mege
Journal:  Clin Vaccine Immunol       Date:  2006-02

5.  Expression of apoptotic epithelial cells within lamina propria beneath the basement membrane triggers dextran sulfate sodium-induced colitis.

Authors:  Kazuko Shichijo; Makoto Ihara; Mohammed Shawkat Razzaque; Mutsumi Matsuu-Matsuyama; Toshiyuki Nakayama; Masahiro Nakashima; Ichiro Sekine
Journal:  Dig Dis Sci       Date:  2008-02-01       Impact factor: 3.199

6.  Characterization of immune inducer and suppressor macrophages from the normal human lung.

Authors:  M A Spiteri; L W Poulter
Journal:  Clin Exp Immunol       Date:  1991-01       Impact factor: 4.330

7.  Lymphocyte and macrophage subpopulations in pelvic ileal pouches.

Authors:  H J de Silva; M Jones; C Prince; M Kettlewell; N J Mortensen; D P Jewell
Journal:  Gut       Date:  1991-10       Impact factor: 23.059

8.  Elimination of local macrophages in intestine prevents chronic colitis in interleukin-10-deficient mice.

Authors:  Norihiko Watanabe; Koichi Ikuta; Kazuichi Okazaki; Hiroshi Nakase; Yasuhiko Tabata; Minoru Matsuura; Hiroyuki Tamaki; Chiharu Kawanami; Tasuku Honjo; Tsutomu Chiba
Journal:  Dig Dis Sci       Date:  2003-02       Impact factor: 3.199

9.  Respiratory burst of intestinal macrophages in inflammatory bowel disease is mainly caused by CD14+L1+ monocyte derived cells.

Authors:  J Rugtveit; G Haraldsen; A K Høgåsen; A Bakka; P Brandtzaeg; H Scott
Journal:  Gut       Date:  1995-09       Impact factor: 23.059

Review 10.  Intestinal drug delivery systems with biodegradable microspheres targeting mucosal immune-regulating cells for chronic inflammatory colitis.

Authors:  Kazuichi Okazaki; Hiroshi Nakase; Norihiko Watanabe; Yasuhiko Tabata; Yoshito Ikada; Tsutomu Chiba
Journal:  J Gastroenterol       Date:  2002-11       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.